A monoclonal antibody, LC-1, recognizing lung cancer associated common antigens was obtained in authors laboratory. Its single chain Fv fragment (ScFv) named LC-1 ScFv was constructed based on recombinant phage displayed techniques. For expression on cell membrane, LC-1 ScFv was cloned into pDisplay vector, which directed the cloned gene to express as cell membrane bound protein. The resulting plasmid was sequenced and then introduced by the lipofectin method into a lung adenocarcinoma cell line SPC-A-1. G418 resistant cells were obtained by G418 selection. After transfection, LC-1 ScFv expression was observed by Western blot analysis and the expression of cognate antigens was down-regulated as shown in ELISA assay. SPC-A-1-pDisplay-ScFv cells grew in vitro at lower speed than the control intact cells and the cells transfected with vacant vector. Flow cytometry analysis detected a substantial increase in G1 phase and decrease in S phase in population of SPC-A-1-pDisplay-ScFv cells compared to SPC-A-1 and SPC-A-1-pDisplay cells. Semi-quantitative RT-PCR analysis showed that c-myc expression was down-regulated in SPC-A-1-pDisplay-ScFv cells. It seems that the antigens recognized by LC-1 may be in some way involved in a growth stimulating pathway and the antibody blocking of the function of the antigens shut down the pathway and thus down-regulate the expression of c-myc and growth of the cells.
INTRODUCTION
Lung cancer remains the leading cause of cancer mortality in the world, accounting for more than one sixth of cancer deaths in the world [1] . Antibodies have been proved to be a powerful tool for the study of lung cancer. A monoclonal IgM antibody, LC-1, was obtained in our laboratory. It can react at a high rate with all four pathological types of lung cancers, including lung adenocarcinoma, lung squamous carcinoma, large cell lung cancer and small cell lung cancer, but not with normal and embryonic tissues [2] . In Western blot analysis, LC-1 detected three protein bands on cell surface of lung adenocarcinoma cell line, SPC-A-1 [3] . ABC staining revealed plenty of targeted antigens (LC-1Ags) on most lung cancer cells while few on normal tissues [2] . Further results indicated that LC-1 recognized the glyco-moiety of LC-1Ags(unpublished data). Experiments showed that when LC-1 bound SPC-A-1 cells, the antigenantibody complexes were internalized via the receptor-mediated endocytic pathway, concentrated in the multivesicular bodies and finally transported to lysosomes for final proteolysis [4] . However, little is known about the nature of LC-1Ags except that they are cell surface glyco-proteins. Moreover, how they function in the lung cancer remains to be solved. All of these indicated that LC-1 may be a useful tool for the study of lung cancer.
Intracellular immunization, which was first introduced in 1988 [5] , is defined as the inhibition or inactivation of the function of a molecule by the ectopic intracellular expression of antisense RNA, ribozyme, dominant negative mutants and others alike which recognize the molecule. ScFvs were applied to intracellular immunization shortly after the first report of ScFv. Persic L. et al reported the creation of a set of vectors which permitted the localization of ScFvs to different intracellular compartments: the endoplasmic reticulum (scFvEer), the nucleus (scFvE-nuclear), the mitochondria (scFvE-mit), the cytoplasm (scFvE-cyto), and as secreted proteins (scFvE-sec) [6] . Biocca S. and his colleagues reported the inactivation of p21ras in Xenopus laevis oocytes based on the intracellular expression of anti-p21ras ScFv genes. They found that cytosolic anti-p21ras ScFv not only markedly inhibited the H1 kinase activity induced by insulin but also blocked the ensuing meiotic maturation [7] .
Here we report the construction of ScFv fragment of LC-1(named LC-1 ScFv, Genbank accession number AF348616), blocking of the function of LC-1Ags with intracellularly expressed LC-1 ScFv, the ensuing inhibition cell growth of lung cancer cells and its possible mechanism.
MATERIALS AND METHODS
Cloning of V H and V L genes of LC-1 LC-1 Hybridoma was raised and kept in our lab. Total RNA was extracted from 10 7 cells with GIBCO-BRL TRIZOL Reagent (GIBCO Cat No. 15596, Rockville, USA) as directed by the manufacturers. cDNA was synthesized using GIBCO-BRL M-MLV (GIBCO Cat. No. 28025-013): 10 μl of 5× first strand buffer, DTT 0.01 M, 1 mM of each dNTPs, 5 μM of random hexamer primers and RNA 20 mg/L in a total volume of 48 μl. The mixture was denatured at 70 for 10 min then chilled on ice for 2 min. After adding 400 U of reverse Transcriptase M-MLV, the mixture was incubated in 37 water bath for 1 h and then inactivated at 95 for 5 min. Primers specific for framework 1 and joining regions were used [8] , vhfor: TGA GGA GAC GGT GAC CGT GGT CCC TTG GCC CAG (3' of VH) and vhbak: AG GTC CAA CTG CAG GAG TCA GG (5' of VH), vlbak: GAC ATT GAG CTC ACC CAG TCT CCA (5' of VL gene), vlfor: G TTT GAT CTC GAG CTT GGT CCC (3' of VL gene). PCR was carried out as described [8] . Amplified fragments were cloned into pBluescript, and sequenced [ABI100 PRISMTM sequencer (PE co.)].
Construction of LC-1 ScFv
Linker primer : C TGG GGC CAA GGG ACC ACG GTC ACC  GTC TCC TCA GGT GGA GGC GGT TCA GGC GGA GGT  GGC TCT GGC GGT GGC GGA TCG GAC ATT GAG CTC  ACC CAG TCT 7 SPC-A-1 cells were coated onto a plate, blocked with 3% NCS (new born calf serum)/PBS and 1012 recombinant phages were applied to the plate for panning, and washed 20 times with PBS and another 20 times with 1% NCS/0.1% Tween 20/PBS. TG1 of OD600 0.3 was added to rescue the bound phages and reinfected for 2 h at 37oC, the rescued phagemids were further subjected to another round of panning and three clones were sequenced.
Introduction of plasmid into SPC-A-1 cell line
Recombinant plasmid was introduced into lung adenocarcinoma cell line SPC-A-1 by lipofectin method as reported [10] with some modification. Briefly: Mature LC-1 ScFv gene was amplified and modified with vlforsacII (5 -ATG CAT CCG CGG CCG TTT GAT CTC CAA CTT GGT CCC-3 ) and vhbaksfi. The resultant LC-1 ScFv was digested with SfiI and SacII and cloned into identically digested pDisplay (Cat N0. V660-20, Invitrogen Co)(shown in Fig 1) . The resulted recombinant plasmid was named pDisplay-ScFv. 15 g pDisplay-ScFv was dissolved into 400 μl serum-free RPMI1640 medium and 15 μl lipofectin (Cat No. 18292-011, Gibco Co.) was dissolved into 400 μl serum-free RPMI1640 medium. These two components were mixed together and incubated at 37 for 1 h. The mixture was used to incubate 5× 10 5 overnight pre-incubated SPC-A-1 cells for 6 h. The treated cells were incubated in RPMI1640/10%NCS for 24 h and then kept in 10% NCS/G418/RPMI1640 for three weeks. Cell colonies were seen. Vacant pDisplay vector and sterile water were also used to transform the cell as controls. SPC-A-1 transfected with vacant pDisplay vector was labeled as SPC-A-1-pDisplay, SPC-A-1 transfected with pDisplay-ScFv as SPC-A-1-pDisplay-ScFv.
ELISA assay of the expression of lung cancer associated antigens 
ECL western blot analysis of the expression of c-myc tagged LC-1 ScFv
To assess the expression of LC-1 ScFv in the transfected SPC-A-1, ECL Western blot analysis was conducted as reported [11] with some modification. Briefly: 5×10
6 cells were lysed in 500ml loading buffer (50 mM Tris-HCl pH 6.8, 100 mM DTT, 2% SDS, 10% glycerol). 20 ml aliquot was subjected to 12% SDS-PAGE eletrophoresis. The separated proteins were transferred to nitrocellulose membrane in transfer buffer (20 mM Tris-HCl, 190 mM Glycine, 20% methanol, pH 8.3) using Mini Trans-blot transfer system (Bio-Rad) at 100V for 1 h. The membrane was blocked with 5% nonfat dried milk in TBST (Tris-buffered saline containing 0.05% Tween-20) and then incubated with mouse anti-human C-MYC first antibody (SC002051, BBST Co). After three washes in TBST, the membrane was incubated with peroxidaseconjugated goat anti-mouse second antibody (SC002050, BBST Co). The blot was incubated with ECL substrate (RPN2109, Amersham Pharmacia Biotech) to reveal the antigen bands and 
Flow cytometry analysis of cell cycle
Propidium iodide (PI) (Sigma, St. Louis, MO) stained cells were prepared and analyzed by flow cytometry (conducted by FACS laboratory of Shanghai Institute of Cell Biology, CAS). Briefly: 5×10 5 cells were seeded in each flask and kept at 37 o C and 5% CO 2 for two days. Cells were then collected, fixed in citrate buffer at room temperature for 1 h, centrifuged at 1000 g and resuspended in PBS at a final concentration of 6×10 6 cells/ml. Cells were stained using 1% PI and 250 U RNase cocktail (RNase A, RNase T1, Ambion Corp., Austin, TX) and incubated in the dark at room temperature for 30 min. Nuclear DNA content was measured based on PI fluorescence using a 488 nm argon laser and a BectonDickinson Sino-American Biotechnology Company, China) was added as a hot start method [13] to eliminate non-specific annealing. GAPDH was used as an internal constant standard. PCR was performed in the following condition: denaturation for 45s at 94
, annealing for 45s at 59 , and extension for 45s at 72 . Initially, c-myc gene was amplified for 7-13 cycles and then the primers for internal standard, GAPDH, were added by the primer-dropping method [14] . After another 14-17 cycles, 17 μl of template of PCR reaction was collected from the following different cycles and templates were then electrophoresed through 1 % agarose gels, and stained with ethidium bromide and photographed. The density of target bands was measured by FURI Smartview-2000 (Shanghai FURI Science and Technology Co, Ltd,). The optimal numbers of PCR cycles were determined.
RESULTS

Sequences of VH and VL and affinity maturation of LC-1 ScFv
In electrophoresis, the isolated total RNA sample gave out three sharp bands, demonstrating the integrity of RNA extracted from hybridoma LC-1 (data not shown). PCR products of V H gene (Genbank accession number AF348614) and V L gene Fig 2  ( Genbank accession number AF348615) can be amplified from reverse transcripted cDNAs. Electrophoresis showed that they were of expected molecular size. Sequences were aligned on NCBI BLAST (http://www.ncbi.nlm.nih.gov/blast/blast. cgi). Results showed that cloned V H and V L gene matched antibody sequence well. Sequence of LC-1 ScFv (Genbank accession number AF348616) showed that V H and V L gene were successfully spliced.
After affinity maturation using phage-display (Fig 5) showed that SPC-A-1-pDisplay-scfv gave a strong signal of c-myc tag but SPC-A-1 cells and SPC-A-1-pDisplay cells lacked of the 30 KD band in ECL Western blot assay.
Comparison of cell growth rate
An interesting phenomenon was that among these different kinds of cells, the SPC-A-1-pDisplay-ScFv cells grew much slower than SPC-A-1 cells or SPC-A-1-pDisplay cells (Fig 6) . It showed that when SPC-A-1 or SPC-A-1-pDisplay cells reached overconfluence, the cell growth of SPC-A-1-pDisplayScFv only reached 40-50%. 
DISUCSSION
LC-1Ags are shared by different lung cancers, as reported earlier by our Lab [2] . In SPC-A-1 cells, the antigens appear to be 51, 70, or 91 KD [3] . Data show there are 7.2×10
4 antigen sites per SPC-A-1 cell [15] .
Functionally blocking a specific protein has been succeeded with antagonists [16] , antisense oligo nucleotide [17] , and antibody [18] . Since Biocca et. al. introduced the idea of intracellular immunization with ScFv, many cellular proteins have been functionally blocked with ScFv [7] .
V H and V L gene of LC-1 have been cloned and their sequences were confirmed by twice fluorescent sequencing. LC-1 ScFv was constructed. After affinity maturation, no mutations occurred in sequence of VH and VL gene. It could be due to high binding activity of LC-1 antibody. It can effectively compete with other phage-display antibodies for binding to the immobilized SPC-A-1 cells and thus all the picked clones were identical with original sequence. We cloned the LC-1 ScFv gene into pDisplay to functionally block the cognate surface glycoproteins. The pDisplay vector features three elements: human cytomegalovirus (CMV) immediate-early promoter/ enhancer which permits efficient, high level expression of the recombinant protein, the murine Ig kchain leader sequence at the N-terminus and platelet derived growth factor receptor transmembrane domain (PDGFR-TM) at the C-terminus, which anchors the fusion protein to the plasma membrane and myc epitope which allows detection of the fusion protein with anti-myc antibody. In western blot analysis, high expression of LC-1 ScFv was detected in SPC-A-1-pDisplay-ScFv cells. In ELISA assay, no remarkable difference in LC-1Ags was detected between A490 of SPC-A-1-pDisplay-ScFv and that of PBS control, while A490 of SPC-A-1 and SPC-A-1-pDisplay cells was remarkably high, indicating that numerous epitopes were bound with LC-1 ScFvs.
Most probably, mechanism implicated in the low detection of LC-1Ags is that the immunocomplexes of LC-1 ScFv and LC-1Ags were internalized via the receptor-mediated endocytic pathway, concentrated in the multivesicular bodies and transported to lysosomes for final proteolysis, similar to the report by Xie W. et al [4] . But we are also aware of another possibility that the immunocomplexes remained on the cell membrane. But LC-1Ags were blocked by LC-1 ScFv, similar to the report by Biocca S. et al [7] .
In our experiments, SPC-A-1-pDisplay-ScFv cells were found to grow slower than SPC-A-1 and SPC-A-1-pDisplay cells. Result of flow cytometry analysis elucidated that there were fewer proliferating SPC-A-1-pDisplay-ScFv cells than that of SPC-A-1 and SPC-A-1-pDisplay cells. In our study, expression of c-myc was found to be down-regulated in SPC-A-1-pDisplay-ScFv cells, while remained high in SPC-A-1 and SPC-A-1-pDisplay cells as quantified by semi-quantitative RT-PCR analysis.
How is the blocking of LC-1Ags by LC-1 ScFv connected with the slowing-down of cell growth and c-myc down-regulation? Studies have shown that many growth factors or regulatory peptides and their receptors are expressed by cancer or adjacent normal cells in the lung, thus providing a series of autocrine or paracrine growth stimulatory loops [19] . Further studies revealed that formation of soft agar clones in vitro and the in vivo growth of xenografts of lung cancer cells in nude mouse were inhibited by neutralizing monoclonal antibody that blocked these stimulatory loops [20] , [21] . Three best characterized autocrine systems in the lung cancer involve GRP/BN and their receptors [20] , Neu differentiation factors (NDF) and their ERBB family receptors [22] , and EGF/TGFa and their receptors [23] . The fact that lung adenocarcinoma cell line SPC-A-1 grows more slowly when intracellularly expressed LC-1 ScFvs block surface expression of LC-1Ags and that soft agar colony formation of SPC-A-1-pDisplayScFv is inhibited (data not published) are highly similar to the inhibition of soft agar colony formation by antibody disturbance as reported [20] , [21] . This suggests that LC-1Ags of SPC-A-1 are possibly involved in an autocrine growth stimulatory loop which stimulates the growth of the cells. When LC-1Ags are blocked by LC-1 ScFv, thus leading to the shutdown of this autocrine loop, cells grow at lower speed. Most growth factor receptors are in some way involved in the signal transduction process, such as GRP/BN receptors belong to the G-protein coupled receptor superfamily [24] .
Myc proteins are transcription factors of helixloop-helix/leucine zipper family that activate transcription as obligate heterodimers with a partner, protein Max [25] . A list of candidate genes activated at transcriptional level by myc was compiled, which contained a number of genes required for cell proliferation [26] . Myc activity is controlled at multiple levels by signal transduction cascades: one such level is c-myc transcription that is strongly induced by growth factors. A second level of control is through proteins that interact with the N-terminal of myc [27] . c-myc, among the so called class II cancer genes, is not altered at DNA level, but affects the phenotype of the host cells by changes in expression [28] . c-myc oncogene, a key oncoprotein in regulation of cell proliferation and apoptosis [29] , was reported to be up-regulated in lung cancer cells [30] . MYC protein promotes normal cell growth and proliferation through direct activation of genes involved in DNA synthesis, RNA metabolism and cell-cycle progression [24] .
We hypothesize that in SPC-A-1, LC-1Ags seem to pick up extracellular signals and then up-regulate the c-myc expression through their signal transduction pathway and thus promote cell growth. When the antigens are blocked, the signal transduct i o n p a t h w a y i s s h u t d o w n , l e a d i n g t o downregulation of the c-myc expression and ensuing slowing down of cell growth.
Our experiments, together with our previous studies [31] , [32] showed LC-1Ags on SPC-A-1 cells could be a good target for lung cancer diagnosis and immunotherapy.
